Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALA-induced Fluorescence Imaging of Breast Cancers Using the Handheld PRODIGI and Eagle Imaging Devices

NCT01837225 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01837225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01837225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALA-induced Fluorescence Imaging of Breast Cancers Using the Handheld PRODIGI and Eagle Imaging Devices
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2010
Completion date
August 31, 2025
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer